Press Releases | BioSenic

Bone Therapeutics treats first patients in PREOB® pivotal phase IIb/III trial for the treatment of non-union fractures

Read more about Bone Therapeutics treats first patients in PREOB® pivotal phase IIb/III trial for the treatment of non-union fractures

Bone Therapeutics’ pivotal phase III osteonecrosis trial with PREOB® hits a new milestone - 30 centres across Europe now active

Read more about Bone Therapeutics’ pivotal phase III osteonecrosis trial with PREOB® hits a new milestone - 30 centres across Europe now active

Bone Therapeutics and partners awarded highly competitive €3.8 million Marie Curie research grant

Read more about Bone Therapeutics and partners awarded highly competitive €3.8 million Marie Curie research grant

Bone Therapeutics to present at Biotech Showcase in San Francisco on Tuesday 14 January, 2014 at 10.15am

Read more about Bone Therapeutics to present at Biotech Showcase in San Francisco on Tuesday 14 January, 2014 at 10.15am

Bone Therapeutics Starts Patient Treatment in First Ever Clinical Trial with Allogeneic Bone Cell Therapy Product

Read more about Bone Therapeutics Starts Patient Treatment in First Ever Clinical Trial with Allogeneic Bone Cell Therapy Product

Bone Therapeutics and Partners awarded over €0.5 million M-ERA.net research funding to develop 3-D patient-tailored bone tissue engineered products

Read more about Bone Therapeutics and Partners awarded over €0.5 million M-ERA.net research funding to develop 3-D patient-tailored bone tissue engineered products

Bone Therapeutics supports pioneering research by backing projects vital to regenerative medicine research (EN)

Read more about Bone Therapeutics supports pioneering research by backing projects vital to regenerative medicine research (EN)

Bone Therapeutics receives clearance for ALLOB® phase II trial in spine fusion

Read more about Bone Therapeutics receives clearance for ALLOB® phase II trial in spine fusion

Bone Therapeutics extends ALLOB® phase I/IIa trial to Germany

Read more about Bone Therapeutics extends ALLOB® phase I/IIa trial to Germany

Bone Therapeutics and Kasios to collaborate on novel product for the optimisation of spinal fusion procedures

Read more about Bone Therapeutics and Kasios to collaborate on novel product for the optimisation of spinal fusion procedures

Subscribe to Press Releases